Related references
Note: Only part of the references are listed.Dystrophia myotonia: why focus on foci?
R. P. Junghans
EUROPEAN JOURNAL OF HUMAN GENETICS (2009)
Doxycycline-controlled splicing modulation by regulated antisense U7 snRNA expression cassettes
J. Marquis et al.
GENE THERAPY (2009)
Rescue of a severe mouse model for spinal muscular atrophy by U7 snRNA-mediated splicing modulation
Kathrin Meyer et al.
HUMAN MOLECULAR GENETICS (2009)
Characterization of a Complex Duchenne Muscular Dystrophy-Causing Dystrophin Gene Inversion and Restoration of the Reading Frame by Induced Exon Skipping
Heidi R. Madden et al.
HUMAN MUTATION (2009)
Theoretic Applicability of Antisense-Mediated Exon Skipping for Duchenne Muscular Dystrophy Mutations
Annemieke Aartsma-Rus et al.
HUMAN MUTATION (2009)
In vivo comparison of 2′-O-methyl phosphorothioate and morpholino antisense oligonucleotides for Duchenne muscular dystrophy exon skipping
Hans A. Heemskerk et al.
JOURNAL OF GENE MEDICINE (2009)
By-passing the nonsense mutation in the 4(CV) mouse model of muscular dystrophy by induced exon skipping
Chalermchai Mitrpant et al.
JOURNAL OF GENE MEDICINE (2009)
Disability and survival in Duchenne muscular dystrophy
M. Kohler et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2009)
Reversal of RNA Dominance by Displacement of Protein Sequestered on Triplet Repeat RNA
Thurman M. Wheeler et al.
SCIENCE (2009)
Antisense masking of an hnRNP A1/A2 intronic splicing silencer corrects SMN2 splicing in Transgenic mice
Yimin Hua et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2008)
DMD pseudoexon mutations: Splicing efficiency, phenotype, and potential therapy
Olga L. Gurvich et al.
ANNALS OF NEUROLOGY (2008)
Antisense, RNAi, and gene silencing strategies for therapy: Mission possible or impossible?
Elizabeth R. Rayburn et al.
DRUG DISCOVERY TODAY (2008)
Clinical approaches in the treatment of Duchenne muscular dystrophy (DMD) using oligonucleotides
Carmen Bertoni
FRONTIERS IN BIOSCIENCE-LANDMARK (2008)
Manufacturing and characterizing AAV-based vectors for use in clinical studies
J. F. Wright
GENE THERAPY (2008)
Immunity to adeno-associated virus vectors in animals and humans: a continued challenge
A. K. Zaiss et al.
GENE THERAPY (2008)
Long-term benefit of adeno-associated virus/antisense-mediated exon skipping in dystrophic mice
Michela Alessandra Denti et al.
HUMAN GENE THERAPY (2008)
Cell-penetrating peptide-conjugated antisense oligonucleotides restore systemic muscle and cardiac dystrophin expression and function
HaiFang Yin et al.
HUMAN MOLECULAR GENETICS (2008)
Sustained dystrophin expression induced by peptide-conjugated morpholino oligomers in the muscles of mdx mice
Natee Jearawiriyapaisarn et al.
MOLECULAR THERAPY (2008)
Exon skipping and Duchenne muscular dystrophy: Hope, hype and how feasible
Steve D. Wilton et al.
NEUROLOGY INDIA (2008)
In vivo delivery of naked antisense oligos in aged mdx mice: Analysis of dystrophin restoration in skeletal and cardiac muscle
Libero Vitiello et al.
NEUROMUSCULAR DISORDERS (2008)
149th ENMC International Workshop and 1st TREAT-NMD Workshop on: “Planning Phase I/II Clinical trials using Systemically Delivered Antisense Oligonucleotides in Duchenne Muscular Dystrophy”
Francesco Muntoni et al.
NEUROMUSCULAR DISORDERS (2008)
Local dystrophin restoration with antisense oligonucleotide PRO051
Judith C. van Deutekom et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
The role of corticosteroids in muscular dystrophy: A critical appraisal
Corrado Angelini
MUSCLE & NERVE (2007)
Injection of a recombinant AAV serotype 2 into canine skeletal muscles evokes strong immune responses against transgene products
K. Yuasa et al.
GENE THERAPY (2007)
Morpholino oligomer -: Mediated Exon skipping averts the onset of dystrophic pathology in the mdx mouse
Sue Fletcher et al.
MOLECULAR THERAPY (2007)
Spinal muscular atrophy:: SMN2 pre-mRNA splicing corrected by a U7 snRNA derivative carrying a splicing enhancer sequence
Julien Marquis et al.
MOLECULAR THERAPY (2007)
Antisense-induced exon skipping for duplications in Duchenne muscular dystrophy
Annemieke Aartsma-Rus et al.
BMC MEDICAL GENETICS (2007)
Antisense oligonucleotide-induced exon skipping across the human dystrophin gene transcript
Steve D. Wilton et al.
MOLECULAR THERAPY (2007)
Enhancement of SMN2 Exon 7 inclusion by antisense oligonucleotides targeting the exon
Yimin Hua et al.
PLOS BIOLOGY (2007)
An intronic element contributes to splicing repression in spinal muscular atrophy
Tsuyoshi Kashima et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Ribonuclease dicer cleaves triplet repeat hairpins into shorter repeats that silence specific targets
Jacelk Krol et al.
MOLECULAR CELL (2007)
Myotonic dystrophy: Emerging mechanisms for DM1 and DM2
Diane H. Cho et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2007)
Muscle chloride channel dysfunction in two mouse models of myotonic dystrophy
John D. Lueck et al.
JOURNAL OF GENERAL PHYSIOLOGY (2007)
Potential of oligonucleotide-mediated exon-skipping therapy for Duchenne muscular dystrophy
Toshifumi Yokota et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2007)
Antisense oligonucleotide-induced exon skipping restores dystrophin expression in vitro in a canine model of DMD
G. McClorey et al.
GENE THERAPY (2006)
Entries in the Leiden Duchenne muscular dystrophy mutation database: An overview of mutation types and paradoxical cases that confirm the reading-frame rule
Annemieke Aartsma-Rus et al.
MUSCLE & NERVE (2006)
Stimulating full-length SMN2 expression by delivering bifunctional RNAs via a viral vector
Travis Baughan et al.
MOLECULAR THERAPY (2006)
Antisense applications for biological control
WH Pan et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2006)
Body-wide gene therapy of Duchenne muscular dystrophy in the mdx mouse model
MA Denti et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Splicing of a critical exon of human survival motor neuron is regulated by a unique silencer element located in the last intron
NK Singh et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Systemic delivery of morpholino oligonucleotide restores dystrophin expression bodywide and improves dystrophic pathology
J Alter et al.
NATURE MEDICINE (2006)
Correction of SMN2 pre-mRNA splicing by antisense U7 small nuclear RNAs
C Madocsai et al.
MOLECULAR THERAPY (2005)
Clinical and molecular aspects of the myotonic dystrophies: A review
L Machuca-Tzili et al.
MUSCLE & NERVE (2005)
Functional analysis of 114 exon-internal AONs for targeted DMD exon skipping: Indication for steric hindrance of SR protein binding sites
A Aartsma-Rus et al.
OLIGONUCLEOTIDES (2005)
Systemic delivery of antisense oligoribonucleotide restores dystrophin expression in body-wide skeletal muscles
QL Lu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
An extended inhibitory context causes skipping of exon 7 of SMN2 in spinal muscular atrophy
NN Singh et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Chimeric RNA/ethylene-bridged nucleic acids promote dystrophin expression in myocytes of Duchenne muscular dystrophy by inducing skipping of the nonsense mutation-encoding exon
A Surono et al.
HUMAN GENE THERAPY (2004)
In vivo selection reveals combinatorial controls that define a critical exon in the spinal muscular atrophy genes
NN Singh et al.
RNA (2004)
Rescue of dystrophic muscle through U7 snRNA-mediated exon skipping
A Goyenvalle et al.
SCIENCE (2004)
Antisense-induced multiexon skipping for Duchenne muscular dystrophy makes more sense
A Aartsma-Rus et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2004)
Insulin receptor splicing alteration in myotonic dystrophy type 2
RS Savkur et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2004)
A muscleblind knockout model for myotonic dystrophy
RN Kanadia et al.
SCIENCE (2003)
Advances in Duchenne muscular dystrophy gene therapy
JCT van Deutekom et al.
NATURE REVIEWS GENETICS (2003)
Functional amounts of dystrophin produced by skipping the mutated exon in the mdx dystrophic mouse
QL Lu et al.
NATURE MEDICINE (2003)
A negative element in SMN2 exon 7 inhibits splicing in spinal muscular atrophy
T Kashima et al.
NATURE GENETICS (2003)
An intronic splicing enhancer element in survival motor neuron (SMN) Pre-mRNA
H Miyaso et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Therapeutic antisense-induced exon skipping in cultured muscle cells from six different DMD patients
A Aartsma-Rus et al.
HUMAN MOLECULAR GENETICS (2003)
Bifunctional antisense oligonucleotides provide a trans-acting splicing enhancer that stimulates SMN2 gene expression in patient fibroblasts
LA Skordis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Correction of disease-associated exon skipping by synthetic exon-specific activators
L Cartegni et al.
NATURE STRUCTURAL BIOLOGY (2003)
Valproic acid increases SMN levels in spinal muscular atrophy patient cells
CJ Sumner et al.
ANNALS OF NEUROLOGY (2003)
Expanded CUG repeats trigger aberrant splicing of CIC-1 chloride channel pre-mRNA and hyperexcitability of skeletal muscle in myotonic dystrophy
A Mankodi et al.
MOLECULAR CELL (2002)
Loss of the muscle-specific chloride channel in type 1 myotonic dystrophy due to misregulated alternative splicing
N Charlet-B et al.
MOLECULAR CELL (2002)
Identification of a cis-acting element for the regulation of SMN exon 7 splicing
H Miyajima et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
The molecular bases of spinal muscular atrophy
T Frugier et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2002)
Three proteins, MBNL, MBLL and MBXL, co-localize in vivo with nuclear foci of expanded-repeat transcripts in DM1 and DM2 cells
M Fardaei et al.
HUMAN MOLECULAR GENETICS (2002)
Disruption of an SF2/ASF-dependent exonic splicing enhancer in SMN2 causes spinal muscular atrophy in the absence of SMN1
L Cartegni et al.
NATURE GENETICS (2002)
Messenger-RNA-binding proteins and the messages they carry
G Dreyfuss et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2002)
Molecular analysis of spinal muscular atrophy and modification of the phenotype by SMN2
MD Mailman et al.
GENETICS IN MEDICINE (2002)
Oligonucleotides against a splicing enhancer sequence led to dystrophin production in muscle cells from a Duchenne muscular dystrophy patient
Y Takeshima et al.
BRAIN & DEVELOPMENT (2001)
Modulation of survival motor neuron pre-mRNA splicing by inhibition of alternative 3′ splice site pairing
SR Lim et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Aclarubicin treatment restores SMN levels to cells derived from type I spinal muscular atrophy patients
C Andreassi et al.
HUMAN MOLECULAR GENETICS (2001)
An in vivo reporter system for measuring increased inclusion of exon 7 in SMN2 mRNA: potential therapy of SMA
ML Zhang et al.
GENE THERAPY (2001)
Treatment of spinal muscular atrophy by sodium butyrate
JG Chang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9
CL Liquori et al.
SCIENCE (2001)
Antisense-induced exon skipping restores dystrophin expression in DMD patient derived muscle cells
JCT van Deutekom et al.
HUMAN MOLECULAR GENETICS (2001)
Effective targeted gene 'knockdown' in zebrafish
A Nasevicius et al.
NATURE GENETICS (2000)
Share Paper
